PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score-Reference-Cited by-同舟云学术

PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score

Published:2023-02-22 Issue:3 Volume:13 Page:611
ISSN:2075-1729
Container-title:Life
language:en
Short-container-title:Life

Author:

Dondi Francesco¹^ORCID,Lazzarato Achille²^ORCID,Gorica Joana³,Guglielmo Priscilla⁴^ORCID,Borgia Francesca⁵,Filice Rossella⁶,Vento Antonio⁷,Pacella Sara⁸^ORCID,Camedda Riccardo⁹^ORCID,Caracciolo Matteo⁵^ORCID,De Feo Maria Silvia³,Mammucci Paolo¹⁰,Frantellizzi Viviana³^ORCID,Ortolan Naima⁵^ORCID,Fiasconaro Elisa¹¹,Urso Luca⁵^ORCID,Evangelista Laura¹²^ORCID,Laudicella Riccardo¹¹¹³^ORCID,Santo Giulia¹⁴^ORCID

Affiliation:

1. Nuclear Medicine, ASST Spedali Civili di Brescia, 25123 Brescia, Italy

2. Unit of Nuclear Medicine, Department of Medicine, Surgery and Pharmacy, Università degli Studi di Sassari, 07100 Sassari, Italy

3. Department of Radiological Sciences, Oncology and Anatomo-Pathology, Sapienza, University of Rome, 00161 Rome, Italy

4. Nuclear Medicine Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy

5. Nuclear Medicine Unit, Oncological Medical and Specialists Department, University Hospital of Ferrara, 44124 Ferrara, Italy

6. Nuclear Medicine Unit, University Hospital “Paolo Giaccone”, Via del Vespro 129, 90127 Palermo, Italy

7. Nuclear Medicine Department, ASP 1-P.O. San Giovanni di Dio, 92100 Agrigento, Italy

8. Nuclear Medicine Department, Fondazione IRCCS Ca’Granda, Ospedale Maggiore Policlinico, via Francesco Sforza 35, 20122 Milan, Italy

9. Department of Biomedicine and Prevention, University of Rome “Tor Vergata”, 00133 Rome, Italy

10. Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Piazza Giulio Cesare 11, 70124 Bari, Italy

11. Nuclear Medicine Unit, S. Antonio Abate Hospital, 54027 Trapani, Italy

12. Department of Medicine DIMED, University of Padua, 35128 Padua, Italy

13. Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and of Morpho-Functional Imaging, University of Messina, 98125 Messina, Italy

14. Department of Experimental and Clinical Medicine, “Magna Graecia” University of Catanzaro, 88100 Catanzaro, Italy

Abstract

Background: in recent years, the role of positron emission tomography (PET) and PET/computed tomography (PET/CT) has emerged as a reliable diagnostic tool in a wide variety of pathological conditions. This review aims to collect and review PET criteria developed for interpretation and treatment response assessment in cases of non-[18F]fluorodeoxyglucose ([18F]FDG) imaging in oncology. Methods: A wide literature search of the PubMed/MEDLINE, Scopus and Google Scholar databases was made to find relevant published articles about non-[18F]FDG PET response criteria. Results: The comprehensive computer literature search revealed 183 articles. On reviewing the titles and abstracts, 149 articles were excluded because the reported data were not within the field of interest. Finally, 34 articles were selected and retrieved in full-text versions. Conclusions: available criteria are a promising tool for the interpretation of non-FDG PET scans, but also to assess the response to therapy and therefore to predict the prognosis. However, oriented clinical trials are needed to clearly evaluate their impact on patient management.

Publisher

MDPI AG

Subject

Paleontology,Space and Planetary Science,General Biochemistry, Genetics and Molecular Biology,Ecology, Evolution, Behavior and Systematics

Link

https://www.mdpi.com/2075-1729/13/3/611/pdf

Reference83 articles.

1. The Basic Principles of FDG-PET/CT Imaging;Basu;PET Clin.,2014

2. Dondi, F., Pasinetti, N., Gatta, R., Albano, D., Giubbini, R., and Bertagna, F. (2022). Comparison between Two Different Scanners for the Evaluation of the Role of 18F-FDG PET/CT Semiquantitative Parameters and Radiomics Features in the Prediction of Final Diagnosis of Thyroid Incidentalomas. J. Clin. Med., 11.

3. Comparison of the EORTC criteria and PERCIST in solid tumors: A pooled analysis and review;Kim;Oncotarget,2016

4. From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors;Wahl;J. Nucl. Med.,2009

5. Comparison of 18F-FDG PET/CT Criteria for the Prediction of Therapy Response and Clinical Outcome in Patients With Metastatic Melanoma Treated With Ipilimumab and PD-1 Inhibitors;Annovazzi;Clin. Nucl. Med.,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of PSMA PET Imaging in the Classification of the Risk of Prostate Cancer Patients: A Systematic Review on the Insights to Guide an Active Surveillance Approach;Cancers;2024-03-11

2. Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies;Clinical Nuclear Medicine;2024-01-23

3. Emerging Role of [18F]FLT PET/CT in Lymphoid Malignancies: A Review of Clinical Results;Hematology Reports;2024-01-11

4. Structured reporting in prostate cancer: the revolution of quality in nuclear medicine scan interpretation;European Radiology;2023-12-20

5. [18F]FDG PET/CT criteria for treatment response assessment: EORTC and beyond;Clinical and Translational Imaging;2023-06-17